Example: stock market
Double Blind Placebo Controlled Multicenter
Found 2 free book(s)
A Phase II, Randomized, Double -blind, Placebo -controlled ...
clinicaltrials.govThis is a multicenter, randomized, double-blind, placebo-controlled phase II study. The trial includes a Run-in Period (if stable conventional treatment needed), a 4-week Screening Period, a 12-week Treatment Period, and a 3-week Safety Follow-up Period to Day 105.
(Progress of Disclosed Matters) First Patient Enrollment ...
pdf.kabutan.jp1 day ago · The Phase III study is a randomized double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of F351 for the treatment of HBV-induced liver fibrosis (ClinicalTrials.gov identifier: NCT05115942). The study is sponsored by Beijing Continent PharmaceuticalCo., Ltd. and will be